1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Biotech stocks often present intriguing, and potentially very lucrative, investment opportunities. Share prices can explode on positive trial results or key regulatory approvals.
The word on Wall Street – from the mouths of several top analysts – is that the market still has some serious room to run. And quality stock picks should be much better rewarded going forward than...
Check out our weekly earnings calendar and read the latest quarterly earnings previews.
More Investing News »